Showing results (381-390 of 2,814) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|September 24, 2009
Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes?Richard M Bergenstal, Nick Freemantle, Malgorzata Leyk, et al.Diabetes Technology & Therapeutics|September 24, 2009
A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trialC Mathieu, R Cuddihy, R F Arakaki, et al.Diabetes Technology & Therapeutics|August 25, 2009
Reconsideration of severe hypoglycemic events in the treat-to-target trialGeorge Dailey, Poul Strange, Matthew RiddleDiabetes Technology & Therapeutics|August 25, 2009
Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetesRamin Alemzadeh, Elaine A Parton, Mary K HolzumDiabetes Technology & Therapeutics|August 25, 2009
Accuracy and reliability of continuous glucose monitoring in individuals with type 1 diabetes during recreational divingPeter Adolfsson, Hans Ornhagen, Johan JendleDiabetes Technology & Therapeutics|August 25, 2009
Cost impact of self-measurement of blood glucose on complications of type 2 diabetes: the Spanish perspectiveKurt Neeser, Christian WeberDiabetes Technology & Therapeutics|August 25, 2009
Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringeCliff Molife, Lauren J Lee, Lizheng Shi, et al.Diabetes Technology & Therapeutics|September 22, 2009
Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetesCamila Guimarães, Carlo A Marra, Lindsey Colley, et al.Diabetes Technology & Therapeutics|September 22, 2009
Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humansTrine Schnedler Clausen, Peter Kaastrup, Bente StallknechtDiabetes Technology & Therapeutics|September 22, 2009
A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4Morten Donsmark, Lars Herold, Carsten Mølgård KristensenPageof 282